Save on Minivelle®
Big savings may be available
Good things come in small patches, and so may big savings!
Eligible patients pay no more than $15 each month for up to 12 uses on their Minivelle® (estradiol transdermal system) prescriptions.*†
Click on the savings offer button to download your offer.
Take the printout to your doctor.
If you and your doctor have decided that Minivelle® is right for you, ask your doctor for a prescription for Minivelle®.
Some mail‑order pharmacies will process the co-pay savings offer when you verbally provide the applicable Group and ID numbers located on your co-pay savings offer. Others will require you to pay the full co-pay amount up front. Please check with your individual mail‑order pharmacy to inquire about the process, as requirements vary.
If your mail‑order pharmacy requires that you pay the full co-pay amount up front, you may apply for a rebate by submitting the downloadable rebate form. You will receive up to $55 in savings for your prescription, after the first $15 is deducted from your total co-pay.*†
Click on the button below to download and print the rebate form.
Complete the form according to its instructions.
Mail or fax the form and related documents to the following address or fax number:
MINIVELLE® (estradiol transdermal system) is a prescription medicine patch that contains estradiol (an estrogen hormone). MINIVELLE is used to treat moderate to severe hot flashes due to menopause.
What is the most important information I should know about MINIVELLE (an estrogen hormone)?
MINIVELLE should not be used if you have unusual vaginal bleeding, currently have or have had certain cancers, had a stroke or heart attack, currently have or have had blood clots, currently have or have had liver problems, have been diagnosed with a bleeding disorder, are allergic to MINIVELLE or any of its ingredients, or think you may be pregnant.
The most common side effects that may occur with MINIVELLE are headache, breast tenderness, back and limb pain, common cold, upset stomach, nausea, inflammation of the sinuses and irregular vaginal bleeding or spotting.
MINIVELLE should be used at the lowest effective dose and for the shortest duration consistent with your treatment goals and risks.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
DOT Matrix™ is a trademark of Noven Pharmaceuticals, Inc.
Minivelle® and the Minivelle Logo are trademarks of Noven Therapeutics, LLC.
Vivelle-Dot® is a registered trademark of Novartis AG.
All other registered trademarks are the property of their respective owners.
For information, call 1‑800‑455‑8070.